Pfizer Plans Viagra for Children

shota-trouble

Drug maker Pfizer plans to release a version of its popular aphrodisiac Viagra for children, as a “humanitarian gesture.”

Pfizer intends to release the new drug under the name of “Revatio.” Both Revatio and Viagra use the same active ingredient, Sildenafil. Viagra has been used for years to treat these disorders.

The new version is intended to treat a condition involving abnormally high blood pressure in the lungs of children, which afflicts 600 children a year in the US.

Unsurprisingly for a pharmaceutical company, its motives are thought to be far from altruistic – the US Food and Drug Administration has offered Pfizer a 6 month extension on its Viagra patent in exchange for pushing the drug.

The patent would otherwise expire in 2012, paving the way for a horde of generic manufacturers to copy the drug and make low cost versions available to consumers.

2009 US sales of Viagra were some $1.9 billion – Pfizer can expect sales of its version to plummet as its monopoly is broken and generics take over the market.

At an effective cost of nearly a billion dollars to treat only 600 patients, it appears “erectile dysfunction” sufferers are getting the shaft in more ways than one. Pfizer shares rose 1.7% on the news.

There is conspicuous silence on the matter of Viagra’s primary effects being applied to young children.

Leave a Comment

88 Comments